Research progress onneoadjuvant therapy in stage ⅢA-N2 non-small cell lung cancer / 中华放射肿瘤学杂志
Chinese Journal of Radiation Oncology
; (6): 61-64, 2020.
Article
в Zh
| WPRIM
| ID: wpr-868550
Ответственная библиотека:
WPRO
ABSTRACT
Ⅲ A-N2 NSCLC is a group of heterogeneous diseases.The optimal treatment modality remains controversial.How to choose suitable neoadjuvant treatment modalities including chemotherapy,radiotherapy,target therapy and immunotherapy remains unclear.In this article,research progress on neoadjuvant therapy of NSCLC was reviewed to evaluate the efficacy and safety for different modalities.
Полный текст:
1
База данных:
WPRIM
Язык:
Zh
Журнал:
Chinese Journal of Radiation Oncology
Год:
2020
Тип:
Article